Cargando…
Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862050/ https://www.ncbi.nlm.nih.gov/pubmed/35211315 http://dx.doi.org/10.1093/ckj/sfab289 |
| _version_ | 1784654987388780544 |
|---|---|
| author | Schnuelle, Peter Kölling, Sebastian Müller, Alexander Schmitt, Wilhelm H |
| author_facet | Schnuelle, Peter Kölling, Sebastian Müller, Alexander Schmitt, Wilhelm H |
| author_sort | Schnuelle, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8862050 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88620502022-02-23 Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine Schnuelle, Peter Kölling, Sebastian Müller, Alexander Schmitt, Wilhelm H Clin Kidney J Letter to the Editor Oxford University Press 2021-12-23 /pmc/articles/PMC8862050/ /pubmed/35211315 http://dx.doi.org/10.1093/ckj/sfab289 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Schnuelle, Peter Kölling, Sebastian Müller, Alexander Schmitt, Wilhelm H Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine |
| title | Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine |
| title_full | Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine |
| title_fullStr | Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine |
| title_full_unstemmed | Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine |
| title_short | Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine |
| title_sort | short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to sars-cov-2 messenger rna vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862050/ https://www.ncbi.nlm.nih.gov/pubmed/35211315 http://dx.doi.org/10.1093/ckj/sfab289 |
| work_keys_str_mv | AT schnuellepeter shorttimeinterruptionofsecondlinemycophenolatetreatmentinapatientwithrenalsarcoidosisenabledamarkedantibodyresponsetosarscov2messengerrnavaccine AT kollingsebastian shorttimeinterruptionofsecondlinemycophenolatetreatmentinapatientwithrenalsarcoidosisenabledamarkedantibodyresponsetosarscov2messengerrnavaccine AT mulleralexander shorttimeinterruptionofsecondlinemycophenolatetreatmentinapatientwithrenalsarcoidosisenabledamarkedantibodyresponsetosarscov2messengerrnavaccine AT schmittwilhelmh shorttimeinterruptionofsecondlinemycophenolatetreatmentinapatientwithrenalsarcoidosisenabledamarkedantibodyresponsetosarscov2messengerrnavaccine |